Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy
- 1 April 1997
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 24 (4) , 368-371
- https://doi.org/10.1007/bf00881807
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Somatostatin Analogues for Somatostatin-Receptor-Mediated Radiotherapy of CancerDigestion, 1996
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationLife Sciences, 1991
- Identification and characterization of somatostatin receptors in neonatal rat long bonesBiochemical Journal, 1990